Publications

Select publications 

For more publications, please view the member profiles.

• Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8(7):e011341, 2023. doi: 10.1136/bmjgh-2022-011341 

• Liu Y, Pearson CAB, Sandmann FG, Barnard RC, Kim JH; CMMID COVID-19 Working Group; Flasche S, Jit M, Abbas K. Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: health impact modelling and benefit-risk analysis. Lancet Regional Health - Europe. 2022 Jun;17:100381. doi: 10.1016/j.lanepe.2022.100381

• Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Scientific Reports. 2021 Mar 4;11(1):5116. doi: 10.1038/s41598-021-84293-8

• Anwari P, Debellut F, Vodicka E, Clark A, Farewar F, Zhwak ZA, Nazary D, Pecenka C, Scott LaMontagne D, Safi N. Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan. Vaccine. 2020 Feb 5;38(6):1352-1362. doi: 10.1016/j.vaccine.2019.12.013

• Abbas K, Procter SR, van Zandvoort K, Clark A, Funk S, Mengistu T, Hogan D, Dansereau E, Jit M, Flasche S; LSHTM CMMID COVID-19 Working Group. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Global Health. 2020 Oct;8(10):e1264-e1272. doi: 10.1016/S2214-109X(20)30308-9

• Anwari P, Debellut F, Pecenka C, Parwiz SM, Clark A, Groman D, Safi N. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan. Vaccine. 2018 Dec 14;36(51):7769-7774. doi: 10.1016/j.vaccine.2017.10.058